Loading
Oryzon Genomics, S.A. Stock: price and insider trades · Spain
Oryzon Genomics, S.A.: what insiders have been doing
Headquartered in Barcelona, Spain, Oryzon Genomics, S.A. belongs to the Health Care sector and traces its origins to 2000. Filings by its managers are published through CNMV. No insider at Oryzon Genomics, S.A. has published a filing in the past twelve months. The most recent one dates from 8 February 2024.
Since 2020, the database holds no purchases and 3 sales by insiders of the company.
This summary is built from CNMV disclosures alone and does not predict where the share price will go.
Key facts
Headquarters: Barcelona, Spain · Founded: 2000
Source: Wikidata (CC0).
Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€2M
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
€2.52
Analyst consensus
3 analysts1.00/5
€4.20Target €7.13(+183%)€12.00
Income statement
Gross profit€10.7M
EBITDA-€4.9M
Net income-€2.6M-15.8% margin
Valuation
PER (forward)280.4x
P/Book1.6x
Beta0.40
Balance sheet & cash
Market cap€206.9M
Total debt€7.6M
Free Cash Flow-€13.4M
Debt / Equity9%
Profitability & ownership
ROE-2.1%
ROA-2.7%
% insiders21.0%
% institutions1.9%
Last declaration on 8 February 2024
Declarations11 total
10,000 shares@ €1.090.0047% mcap30.5% of flowShareXOOFISIN ES0167733015CNMV:2024020827
15,000 shares@ €1.090.0070% mcap22.5% of flowShareXOOFISIN ES0167733015CNMV:2024020824
10,000 shares@ €2.560.011% mcap35.3% of flowShareXOOFISIN ES0167733015CNMV:2023022698
10,000 shares@ €2.480.011% mcap69.5% of flowShareXOOFISIN ES0167733015CNMV:2023021941
12,000 shares@ €2.530.013% mcap53.8% of flowShareXOOFISIN ES0167733015CNMV:2023020065
36,900 shares@ €2.30100.0% of flowShareXBARISIN ES0167733015CNMV:2022119049
12,000 shares@ €2.5542.2% of flowShareXOOFISIN ES0167733015CNMV:2022106902
10,000 shares@ €2.6146.2% of flowShareXOOFISIN ES0167733015CNMV:2022092563
250,000 shares@ €3.72ShareXXXXISIN ES0167733015CNMV:2020137429
250,000 shares@ €3.72ShareXXXXISIN ES0167733015CNMV:2020137433
00ShareXXXXISIN ES0167733015CNMV:2020041871
11 of 11 declarations
About Oryzon Genomics, S.A.
Oryzon Genomics, S.A. is a biopharmaceutical company focused on developing innovative therapies for the treatment of neurodegenerative diseases and cancers. It is listed on the XMAD market.
